Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRay GroupSHSE:688301 -2.07%95 Market Cap is ¥27,749 Mil as of Sep. 11, 2026. GuruFocus rates SHSE:688301 with a GF Score™ of 95/100 and a GF Value™ of ¥109.99 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 860 Medical Devices & Instruments companies, iRay Group ranks better than 91.74% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). iRay Group's share price for the quarter that ended in Jun. 2026 was ¥124. iRay Group's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 312 Mil. Therefore, iRay Group's market cap for the quarter that ended in Jun. 2026 was ¥38,700 Mil.
iRay Group's quarterly market cap
increased
from Dec. 2025 (¥21,380 Mil) to Mar. 2026 (¥22,982 Mil) and
increased
from Mar. 2026 (¥22,982 Mil) to Jun. 2026 (¥38,700 Mil).
iRay Group's annual market cap
declined
from Dec. 2023 (¥33,174 Mil) to Dec. 2024 (¥13,673 Mil) but then
increased
from Dec. 2024 (¥13,673 Mil) to Dec. 2025 (¥21,380 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. iRay Group's Enterprise Value for Today is ¥28,674 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
iRay Group Market Cap Related Terms
iRay Group Market Cap Historical Data
* Premium members only.
The historical data trend for iRay Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688301 vs ISRG, BDX, RMD: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, iRay Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRay Group Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRay Group's Market Cap distribution charts can be found below:
* The bar in red indicates where iRay Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
iRay Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRay Group (SHSE:688301) has a Market Cap of ¥27,749 Mil as of Sep. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on iRay Group and its competitors. According to the industry distribution chart, iRay Group ranks #71 out of 860 companies in the Medical Devices & Instruments industry, placing it in the top 8.3%.
Is iRay Group's Market Cap too high?
iRay Group's current Market Cap is ¥27,749 Mil. Based on the distribution chart, iRay Group ranks #71 out of 860 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, iRay Group has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRay Group's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iRay Group ranks #71 out of 860 companies for Market Cap. This places iRay Group in the top 8% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 119.16, based on 860 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on iRay Group and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 119.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRay Group's current Market Cap is ¥27,749 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRay Group stock overvalued right now?
Based on GuruFocus' analysis, iRay Group (SHSE:688301) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥109.99, compared to a current price of ¥88.54 — trading 19.5% below its estimated fair value. The current Market Cap is ¥27,749 Mil. iRay Group's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For iRay Group (SHSE:688301), the current Market Cap is ¥27,749 Mil as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRay Group (SHSE:688301) Overvalued in 2026?
Based on GuruFocus' analysis, iRay Group stock appears to be undervalued.
The current stock price of ¥88.54 is trading 19.5% below its estimated GF Value™ of ¥109.99.
GuruFocus considers iRay Group to be Modestly Undervalued.
Key valuation signals for SHSE:688301:
Market Cap: ¥27,749 Mil
GF Value™: ¥109.99 vs. price of ¥88.54 (19.5% below fair value)
No single metric tells the full story. See the SHSE:688301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688301 has been successfully added to your 
